New kidney disease treatment enters human testing
Disease control
Recruiting now
This study is testing whether two intravenous infusions of an experimental drug called AION-301 are safe and might help people with moderate chronic kidney disease. Researchers will compare the drug to a placebo in 36 participants to see if it reduces kidney-related symptoms or s…
Phase: PHASE1, PHASE2 • Sponsor: AION Healthspan, Inc. • Aim: Disease control
Last updated Apr 23, 2026 12:43 UTC